Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Drug Safety
List of Issues
Volume 12, Issue 4

Expert Opinion on Drug Safety

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Drug Safety, Volume 12, Issue 4 (2013)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Drug Safety, Volume 12, Issue 4 (2013)

See all volumes and issues

Vol 23, 2024 Vol 22, 2023 Vol 21, 2022 Vol 20, 2021 Vol 19, 2020 Vol 18, 2019 Vol 17, 2018 Vol 16, 2017 Vol 15, 2016 Vol 14, 2015 Vol 13, 2014 Volume 12, 2013 Vol 11, 2012 Vol 10, 2011 Vol 9, 2010 Vol 8, 2009 Vol 7, 2008 Vol 6, 2007 Vol 5, 2006 Vol 4, 2005 Vol 3, 2004 Vol 2, 2003 Vol 1, 2002

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Original Research

Article

Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain

Daniel Castellano MD, Mei Sheng Duh MPH ScD, Caroline Korves ScD, Ellison Dial Suthoff MBA, Maureen Neary MS PhD, Luis Javier Hernández Pastor PharmD PhD & Joaquim Bellmunt MD

Pages: 455-463

Published online: 20 Mar 2013

AbstractforSafety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain | Full Text | References | PDF (247.9 KB)

198 Views
3 CrossRef citations
0Altmetric

Article

Safety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials

Margaret Noyes Essex PharmD, Richard Y Zhang PhD, Manuela F Berger MD, Sameer Upadhyay MD & Peter W Park PhD

Pages: 465-477

Published online: 19 Mar 2013

AbstractforSafety of celecoxib compared with placebo and non-selective NSAIDs: cumulative meta-analysis of 89 randomized controlled trials | Full Text | References | PDF (340.1 KB)

966 Views
21 CrossRef citations
0Altmetric

Meta-Opinion

Article

Rasagiline meta-analysis: a spotlight on clinical safety and adverse events when treating Parkinson's disease

Julián Solís-García del Pozo, Sara Mínguez-Mínguez, Piet WJ de Groot & Joaquín Jordán

Pages: 479-486

Published online: 02 May 2013

AbstractforRasagiline meta-analysis: a spotlight on clinical safety and adverse events when treating Parkinson's disease | Full Text | References | PDF (411.6 KB)

600 Views
11 CrossRef citations
0Altmetric

Reviews

Review Article

Drug-induced parkinsonism

José López-Sendón, Maria A Mena & Justo G de Yébenes

Pages: 487-496

Published online: 31 Mar 2013

AbstractforDrug-induced parkinsonism | Full Text | References | PDF (339.9 KB)

1634 Views
64 CrossRef citations
0Altmetric

Review Article

Risks associated with the therapeutic use of fluoroquinolones

Ralf Stahlmann & Hartmut M Lode

Pages: 497-505

Published online: 07 May 2013

AbstractforRisks associated with the therapeutic use of fluoroquinolones | Full Text | References | PDF (334.6 KB)

1809 Views
88 CrossRef citations
0Altmetric

Review Article

Safety concerns with the long-term management of osteoporosis

Jean-Yves Reginster PhD MD, Franz Pelousse MD & Olivier Bruyère PhD

Pages: 507-522

Published online: 24 Apr 2013

AbstractforSafety concerns with the long-term management of osteoporosis | Full Text | References | PDF (308.8 KB)

644 Views
21 CrossRef citations
0Altmetric

Review Article

Potential nephroprotective effects of l-carnitine against drug-induced nephropathy: a review of literature

Atefeh Jafari, Simin Dashti-Khavidaki, Hossein Khalili & Mahboob Lessan-Pezeshki

Pages: 523-543

Published online: 08 May 2013

AbstractforPotential nephroprotective effects of l-carnitine against drug-induced nephropathy: a review of literature | Full Text | References | PDF (342.8 KB)

298 Views
11 CrossRef citations
0Altmetric

Review Article

Gliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis

Andre Scheen

Pages: 545-557

Published online: 27 Apr 2013

AbstractforGliptins (dipeptidyl peptidase-4 inhibitors) and risk of acute pancreatitis | Full Text | References | PDF (447.1 KB)

1428 Views
35 CrossRef citations
0Altmetric

Drug Safety Evaluations

The safety and efficacy of apixaban: where do we stand in 2013?

Flavio de Souza Brito MD, Renato D Lopes MD PhD & John H Alexander MD MHS

Pages: 559-567

Published online: 10 May 2013

AbstractforThe safety and efficacy of apixaban: where do we stand in 2013? | Full Text | References | PDF (241.4 KB)

338 Views
3 CrossRef citations
0Altmetric

Efficacy and safety of mipomersen sodium (Kynamro)

Kees Hovingh, Joost Besseling & John Kastelein

Pages: 569-579

Published online: 23 Apr 2013

AbstractforEfficacy and safety of mipomersen sodium (Kynamro) | Full Text | References | PDF (557.3 KB)

479 Views
25 CrossRef citations
0Altmetric

Safety evaluation of leflunomide in rheumatoid arthritis

Helen I Keen MBBS FRACP PhD, Philip G Conaghan MBBS PhD FRACP FRCP & Susan E Tett PhD BPharm(Hons)

Pages: 581-588

Published online: 14 May 2013

AbstractforSafety evaluation of leflunomide in rheumatoid arthritis | Full Text | References | PDF (398 KB)

768 Views
40 CrossRef citations
0Altmetric

Meeting Highlights

Meeting Report

2012 Annual Meeting of the Safety Pharmacology Society: spotlight on targeted oncology medicines

Icilio Cavero

Pages: 589-603

Published online: 14 May 2013

Abstractfor2012 Annual Meeting of the Safety Pharmacology Society: spotlight on targeted oncology medicines | Full Text | References | PDF (404.3 KB)

225 Views
8 CrossRef citations
0Altmetric

Research Article

Article

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Compartment syndrome associations with drugs: a pharmacovigilance study of the FDA adverse event reporting system (FAERS)

Wenqiang Kong et al.

Article | Published online: 8 Jul 2024

PARP inhibitor-related acute renal failure: a real-world study based on the FDA adverse event reporting system database

Xiayang Ren et al.

Article | Published online: 8 Jul 2024

Open Access

Analysis of hemorrhagic drug-drug interactions between P-gp inhibitors and direct oral anticoagulants from the FDA Adverse Event Reporting System

Mengyao Li et al.

Article | Published online: 8 Jul 2024

A real-world pharmacovigilance study of FDA adverse event reporting system events for atogepant

Heli Wen et al.

Article | Published online: 8 Jul 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Drug Safety (Vol.12, Iss.4, 2013)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?